Christopher E. Kubasik - Feb 28, 2025 Form 4 Insider Report for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Role: Chair and CEO, Director
Signature: By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik
Stock symbol: LHX
Transactions as of: Feb 28, 2025
Transactions value $: -$2,139,216
Form type: 4
Date filed: 3/4/2025, 06:55 PM
Previous filing: Feb 27, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LHX	Common Stock, Par Value $1.00	Options Exercise	$0	+26.4K	+23.21%	$0.00	140K	Feb 28, 2025	Direct	F1
transaction	LHX	Common Stock, Par Value $1.00	Tax liability	-$2.14M	-10.4K	-7.41%	$206.11	130K	Feb 28, 2025	Direct
holding	LHX	Common Stock, Par Value $1.00						53.8K	Feb 28, 2025	By grantor retained annuity trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LHX	Performance Stock Units	Options Exercise	$0	-24.6K	-100%	$0.00	0	Feb 28, 2025	Common Stock, Par Value $1.00	24.6K	$0.00	Direct	F2
transaction	LHX	Non-Qualified Stock Option (Right to Buy)	Award	$0	+72K		$0.00	72K	Feb 28, 2025	Common Stock, Par Value $1.00	72K	$206.11	Direct	F3
transaction	LHX	Restricted Stock Units	Award	$0	+17.2K		$0.00	17.2K	Feb 28, 2025	Common Stock, Par Value $1.00	17.2K	$0.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Settlement of performance stock units granted on 2/25/2022 (previously reported) in shares of common stock following the end of the 3-year performance period. Includes 1,749 shares earned in excess of the amount previously reported as performance stock units based on the performance stock unit payout formula.
F2	Award of performance stock units that vested on 1/3/2025 following the end of the 3-year performance period and were settled in shares of common stock on 2/28/2025 based on the performance stock unit payout formula.
F3	Options to purchase shares of common stock generally vest ratably on 2/28/2026, 2/28/2027 and 2/28/2028 and remain exercisable, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.
F4	Award of restricted stock units subject to future vesting on 2/28/2028, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares of common stock. Does not include performance stock units granted on 2/28/25, which vest solely upon achievement of pre-established performance goals over a 3-year performance period.